Buy a 5 mg vial, 6 mg pen or 10 mg spray.
AOD9604 5 mg vial
5 mg per vial · lyophilized powder
The vial arrives dry. Its concentration depends on the final prepared volume; the packaging’s “3 mL vial” describes container capacity.
Checkout unavailable
Label claim: 5 mg. The supplied certificate identifies powder lot PL-2609-006.
AOD9604 6 mg pen
6 mg per pen · 3 mL · 2 mg/mL
The pen contains a prepared solution and 20% more labeled peptide than one 5 mg vial. A verified click-to-volume calibration was not supplied.
Checkout unavailable
The stated 2 mg/mL is a product specification. The powder COA does not assay the finished pen.
AOD9604 10 mg spray
10 mg per bottle · supplied liquid · spray output unresolved
The front and side labels give conflicting information about the amount per spray. The total bottle claim is 10 mg; its exact liquid volume is not established.
Checkout unavailable
A 100 mcg front-label claim conflicts with the side-label total divided by its stated spray count.
Actual product-gallery images and listing specifications reviewed November 7, 2026. The vial image is framed to show the original vial and carton without the outer promotional banners; packaging artwork is retained. The products are labeled for laboratory research. No checkout destination has been provided.
The amount, concentration and delivery device are separate details.
All three listings name AOD-9604. Changing its presentation changes preparation and measurement; equal labeled milligrams do not establish equal absorption or effects across routes.
| Detail | 5 mg vial | 6 mg pen | 10 mg spray |
|---|---|---|---|
| Labeled total amount | 5 mg | 6 mg | 10 mg |
| Supplied form | Lyophilized powder | Prefilled solution | Liquid in a spray bottle |
| Supplied liquid volume | None; the 3 mL label is vial capacity | 3 mL | Exact fill volume not confirmed |
| Concentration | 5 mg ÷ final volume in mL | 2 mg/mL; 0.2% w/v | Listing gives ≤0.1% w/v, not an exact concentration |
| Additional ingredients | An included diluent is not confirmed | Listing: bacteriostatic water with 0.9% benzyl alcohol | Listing and photographed ingredient label disagree; see below |
| Equipment | Sealed vial and carton shown; preparation supplies are not confirmed | 3 mL glass cartridge in a pen; a fitted needle is described, but spares are not confirmed | Metered pump and cap shown; output calibration is not supplied |
| Amount delivered | Requires concentration and a verified volume measurement | mL can be calculated; clicks cannot be inferred | Front and side-label claims do not reconcile |
| Supplied laboratory report | Named 5 mg powder lot | Powder reference only; no finished-pen result | Powder reference only; no finished-spray result |
The certificate identifies AOD-9604, Tyr-hGH(177–191), with a tyrosine at the start of its 16-residue sequence. Keep the exact compound name attached when comparing a listing or study with “HGH fragment 176–191.” Read the reported identity ↗
100 mcg per spray does not match 10 mg across 200 sprays.
Printed “per spray.”
10,000 mcg ÷ 200 stated sprays.
The side label says 10,000 mcg per bottle and 200 sprays per bottle. If both claims described delivered content, the average would be 50 mcg per spray. Conversely, 200 sprays at the front label’s 100 mcg would require 20 mg.
Those calculations expose the discrepancy; they do not establish which label is correct or how much the pump actually delivers. No calibrated output report, confirmed fill volume or reconciliation was supplied.
The side label’s “100–400 mcg” research-amount line supplies no frequency. It is not a clinical schedule, and it does not resolve the pump-output discrepancy.
The vial starts dry; the pen and spray arrive as liquids.
VialDry powder → establish a suitable preparation and final volume → calculate concentration.
PenPrefilled solution → use the listed 2 mg/mL for arithmetic → verify device calibration separately.
SpraySupplied liquid → resolve formulation and output claims → establish the actual pump specification.
The pen removes the powder-mixing step. That convenience does not supply a click setting, a validated in-use period or finished-product test results. Likewise, the spray’s ready-made presentation does not establish absorption or an amount per actuation.
| Format | Stated storage | Duration limit |
|---|---|---|
| Sealed powder vial | −20°C, desiccated and dark | The original powder-lot report prints September 18, 2028 as retest/expiry under its stated conditions. |
| Reconstituted vial | The listing says 2–8°C, protected from light | Only for a period established by the laboratory; no numeric period is supplied. |
| Prefilled pen | 2–8°C in the original carton, away from light, capped between uses; do not freeze | No verified opened-pen period is supplied. |
| Spray bottle | 2–8°C, upright, capped and protected from light; do not freeze | No verified in-use period is supplied. |
The powder retest date is not an expiry for a freshly prepared solution, an opened pen or a spray bottle. A mathematically calculated number of portions also does not establish how long a container remains usable. Original powder-lot storage and dates ↗
Price per milligram starts with the stated container amount.
Use a real quoted price for each format. The site has no configured price or checkout, and a product’s total mass does not make different routes interchangeable.
Quoted vial price ÷ 5
Gives the price per labeled milligram before preparation supplies or losses.
Quoted pen price ÷ 6
Compare its prepared-liquid format and verified specifications separately from cost.
Quoted bottle price ÷ 10
This uses the total-content claim, not the unresolved amount per spray.
| Nominal amount to cover | 5 mg vials | 6 mg pens | 10 mg bottles |
|---|---|---|---|
| 10 mg | 2 vials = 10 mg | 2 pens = 12 mg | 1 bottle = 10 mg |
| 30 mg | 6 vials = 30 mg | 5 pens = 30 mg | 3 bottles = 30 mg |
For another total, divide by the amount per container and round the container count up. Account separately for priming, residual liquid, preparation losses, expiry, supplies and delivery charges. The course quantity calculator performs arithmetic from entries you supply; it does not choose a regimen.
The supplied COA belongs to the 5 mg powder lot.
AOD-9604 5 mg
- Powder lot
- PL-2609-006
- Certificate
- PL-26-00006
- Reported HPLC purity
- 99.58%
- Issued
- October 3, 2026
Purity, identity and total content answer different questions.
The report gives an HPLC area-purity result and a mass-identity result, plus water, endotoxin and no-growth testing for sampled powder. It does not separately assay the labeled 5 mg fill.
Placing that document beside a pen or spray does not create a finished-solution assay or a record of how much its device delivers. The Quality + COA guide checks the printed peak arithmetic and explains every reported test.